Merck buys Prometheus Biosciences for nearly $11bn
Merck has agreed to purchase Prometheus Biosciences for $10.8bn because the US drugmaker bolsters it pipeline ...
Read more
Tag: 11bn
Premium Content
![TFSA Buyers: 10 Shares Each Canadian Ought to Personal in 2023 [PREMIUM PICKS]](https://www.fool.ca/wp-content/uploads/2023/01/runner-tying-her-shoes-preparing-for-a-jog-outside-scaled.jpg)
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.